Contrary Capital

Portfolio Co Investors 2026 for Contrary Capital: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Contrary Capital accounts for 7 tracked companies with verified cap-table data, 7 of which disclose round sizes totalling $3.7B. The median disclosed raise is $230M, and the largest is Zepto at $1.9B, ahead of ACELYRIN ($758M) and Juniper Square ($499M).

The names that recur most often on these co-invested cap tables are Contrary Capital (7 companies), Y Combinator (2 companies), General Catalyst (2 companies), OrbiMed (2 companies), Chemistry VC (2 companies), Pareto Holdings (2 companies). By latest disclosed round, the market skews Series B (2), Seed (2), Series F (1), Series C (1).

Best funded Contrary Capital companies

  1. Zepto — $1.9B (latest: Series F)
  2. ACELYRIN — $758M (latest: Series C)
  3. Juniper Square — $499M (latest: Series D)
  4. AtoB — $230M (latest: Series B)
  5. Lightyear — $142M (latest: Series B)
  6. Moment — $134M (latest: Seed)
  7. Kaspien — $2M (latest: Seed)

Contrary Capital — related firms and companies (49)

Contrary Capital profile · All research reports